Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome

BACKGROUND: Despite advances in supportive care, moderate-severe acute respiratory distress syndrome (ARDS) is associated with high mortality rates, and novel therapies to treat this condition are needed. Compelling pre-clinical data from mouse, rat, sheep and ex vivo perfused human lung models supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kathleen D, Wilson, Jennifer G, Zhuo, Hanjing, Caballero, Lizette, McMillan, Melanie L, Fang, Xiaohui, Cosgrove, Katherine, Calfee, Carolyn S, Lee, Jae-Woo, Kangelaris, Kirsten N, Gotts, Jeffrey E, Rogers, Angela J, Levitt, Joseph E, Wiener-Kronish, Jeanine P, Delucchi, Kevin L, Leavitt, Andrew D, McKenna, David H, Thompson, B Taylor, Matthay, Michael A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273700/
https://www.ncbi.nlm.nih.gov/pubmed/25593740
http://dx.doi.org/10.1186/s13613-014-0022-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273700/
https://www.ncbi.nlm.nih.gov/pubmed/25593740
http://dx.doi.org/10.1186/s13613-014-0022-z

Ejemplares similares